Investment Partners Asset Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$554K Hold
2,201
0.31% 90
2026
Q1
$479K Hold
2,201
0.3% 96
2025
Q4
$503K Sell
2,201
-66
-3% -$15K 0.31% 88
2025
Q3
$525K Hold
2,267
0.35% 89
2025
Q2
$421K Sell
2,267
-166
-7% -$30.9K 0.29% 105
2025
Q1
$510K Buy
2,433
+148
+6% +$28.8K 0.4% 77
2024
Q4
$406K Hold
2,285
0.32% 95
2024
Q3
$451K Hold
2,285
0.37% 86
2024
Q2
$392K Hold
2,285
0.35% 88
2024
Q1
$416K Buy
2,285
+198
+9% +$34.1K 0.38% 81
2023
Q4
$323K Buy
+2,087
New +$304K 0.32% 93

Other funds holding ABBV

Investment Partners Asset Management's ABBV Position: Q2 2026 in Review

Investment Partners Asset Management held its AbbVie (ABBV) position steady in Q2 2026 at 2,201 shares worth $554K. The position accounts for 0.31% of the portfolio, ranked #90.

Investment Partners Asset Management first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. 1,602 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Investment Partners Asset Management held 2,201 shares of AbbVie worth $554K as of Q2 2026.
  • Investment Partners Asset Management left its AbbVie share count unchanged in Q2 2026.
  • AbbVie made up 0.31% of Investment Partners Asset Management's portfolio in Q2 2026, its #90 holding.
  • Investment Partners Asset Management first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
  • 1,602 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Investment Partners Asset Management's 13F filing for Q2 2026, filed 24 Jul 2026.